Relation Between Thyroid Hormones and Insulin Resistance in Hemodialysis Patients
First Online: 15 December 2009 Received: 11 August 2009 Accepted: 16 November 2009 DOI:
10.1007/s00596-009-0126-x Cite this article as: Abdelwhab, S. & Foda, O. Kidney (2010) 19: 66. doi:10.1007/s00596-009-0126-x Abstract
Insulin resistance (IR) is a common problem in patients with ESRD on regular HD, and it is related to many complications, including cardiovascular complications, the major killer in these patients. Disorders of thyroid function are common in patients with ESRD. Many factors have been claimed to contribute to IR in HD patients. Our aim is to study the relations between thyroid hormones and IR in HD patients for better understanding and management of IR. The study involved 35 patients with ESRD under regular HD (group 1) and 20 normal control subjects (group 2). All of them underwent complete history taking and clinical examination: biochemical and hematological, thyroid hormones TSH, free T3 (FT3) and free T4 (FT4), and insulin resistance using the homeostasis model assessment (HOMA-IR). Patients with DM and those with known thyroid disorders were excluded from the study. Comparing HD patients and normal control subjects shows significant differences as regards FT3 (p = 0.04) 33.58 ± 12.14 vs. 40.63 ± 11.27 pg/l, respectively; TSH (p = 0.03) 3.29 ± 3.83 vs. 1.80 ± 0.88 mu/l, respectively; fasting insulin level (p < 0.001) 30.1 ± 6.05 vs. 10.68 ± 2.77 mu/ml, respectively; HOMA (p < 0.001) 6.72 ± 1.41 vs. 2.4 ± 0.67, respectively. There is no significant difference as regards FT4 (p = 0.36) 15.17 ± 6.72 vs. 16.35 ± 2.66 pmol/l, respectively. Bivariate correlation in HD patients shows HOMA IR correlates with FT3 (p < 0.001), FT4 (p < 0.001), TSH (p < 0.001), HDL (p < 0.001), and hematocrit (p < 0.001). No correlations were found with BMI, age, total cholesterol, LDL, or triglycerides. Linear regression analysis showed HOMA-IR was independently determined by HDL (p = 0.04), hematocrit (p = 0.02), and TSH (p = 0.008). IR is very common in HD patients. There is a close correlation between IR and thyroid hormones. TSH, HDL, and hematocrit levels independently determine IR. Regular follow-up of these factors is necessary for proper management of IR.
Keywords Insulin resistance Thyroid hormones Hemodialysis End-stage renal disease Abbreviations IR
end-stage renal disease
homeostasis model assessment
Linder A, Charra B, Sherpard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290:697–701.
Mak RHK. Renal disease, insulin resistance and glucose intolerance. Diabetes. 1994;2:19–28.
Ikeda T, Gomi T, Hirawa N, Sakurai J, Yoshikawa N. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension. 1996;27:1180–6.
Mak RHK, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron. 1992;61:377–82.
De pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol. 2007;67(2):265–9.
Bakker SJ, Ter Maaten JC, et al. The relationship between thyrotropin and low-density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab. 2001;86:1206–11.
Singh PA, Bobby Z, Selvaraj N, Vinayagamoorthi R. An evaluation of thyroid hormone status and oxidative stress in undialyzed chronic renal failure patients. Indian J Physiol Pharmacol. 2006;50:279–84.
Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev. 1996;17:45–63.
Iglesias P, Dı´ez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol. 2009;160:503–15.
Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21:2191–2.
Shoji T, Emoto M, YN. HOMA index to assess insulin resistance in renal failure patients. Nephron. 2001;89:348-9.
Shinohara K, Shoji T, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:1894–900.
Despres JP, Lamarche B, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952–7.
Sit D, Kadiroglu AK, Kayabasi H, Yilmaz ME. The prevalence of insulin resistance in nondiabetic nonobese patients with chronic kidney disease. Adv Ther. 2006;23:988–98.
Chen HH, Wu CJ, et al. Metabolic syndrome is associated with severe coronary artery disease and poor cardiac outcome in end-stage renal disease patients with acute coronary syndrome. Coron Artery Dis. 2006;17:593–6.
Stefanovi V, Nesi V, Stojimirovi B. Treatment of insulin resistance in uremia. Int J Artif Organs. 2003;26(2):100–4.
Tonshoff B, Kiepe D, S C. Growth hormone/ insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol. 2005;20, 279–89.
Fortes PC, de Moraes TP, et al. Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int. 2009;29:S145–8.
Wada T, Miyata T, Kurokawa K. Implication of carbonyl stress in long-term uremic complications. Nephrol Dial Transplant. 1999;14(1):79–81.
Lim VS. Thyroid function in patients with chronic renal failure. Am J Kid Dis. 2001;38(1):80–4.
Lin C, Chen TW, Ng YY, Chou YH, WC Y. Thyroid dysfunction and nodular goiter in hemodialysis and peritoneal dialysis patients. Perit Dial Int. 1998;18:516–21.
Dulau IA, Popescu G, et al. Thyroid hormones clearance through the dialysis membrane determines a higher incidence of thyroid disease in patients on maintenance hemodialysis (abstract). Nephrol Dial Transplant. 2000;15(9):A149.
Yonemura K, Nakajima T, et al. Low free thyroxine concentrations and deficient nocturnal surge of thyroid-stimulating hormone in haemodialysed patients compared with undialysed patients. Nephrol Dial Transplant. 2000;15(5):668–72.
Stouthard JM, van der PT, et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 1994;79:1342–6.
Liu YY, Schultz JJ, Brent GA. A thyroid hormone receptor gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J Biol Chem. 2003;278:38913–20.
Fernández-Real JM, López-Bermejo A, Castro A, Casamitjana R, Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab. 2006;91(9):3337–43.
Malavazos AE, Cereda E, et al. Thyroid function and body weight: should we also consider the interplay with insulin resistance and fat distribution. Arch Intern Med. 2008;168:2284–5.
Kumar HK, Yadav RK, et al. Association between thyroid hormones, insulin resistance, and metabolic syndrome. Saudi Med J. 2009;30(7):907–11.
Jameson JL. Mechanisms of thyroid hormone action. Philadelphia: WB Saunders; 2001.
Dimitriadis G, Mitrou P, et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab. 2006;91:4930–7.
Bakker SJ, ter Maaten JC, et al. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab. 2001;86:1206–11.
Amati F, Dubé JJ, Stefanovic-Racic M, Toledo FG, Goodpaster BH. Improvements in insulin sensitivity are blunted by subclinical hypothyroidism. Med Sci Sports Exerc. 2009;41(2):265–9.
Loeb JN. Catecholamines and the sympathoadrenal system in thyrotoxicosis. Philadelphia: Lippincott; 1996.
Chubb SA, Davis WA, Davis TM. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab. 2005;90:5317–20.
Koritschoner NP, Alvarez-Dolado M, et al. Thyroid hormone regulates the obesity gene tub. EMBO Rep. 2001;2:499–504.
Levine JA, Nygren J, Short KR, Nair KS. Effect of hyperthyroidism on spontaneous physical activity and energy expenditure in rats. J Appl Physiol. 2003;94:165–70.
Wang H, Chu WS, et al. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol Endocrinol Metab. 2004;286:E1–7.
Cheng SC, Chu TS, et al. Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD. Perit Dial Int. 2001;21:282–9.
Murase T, Cattran DC, Rubenstein B, Steiner G. Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metabolism. 1975;24(11):1279–86.
Lee SW, Park Geun Ho, et al. Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients. Nephrol Dial Transplant. 2007;22:2554–62.
Szu-Chun H, Der-Cherng T. Adiposity and insulin resistance in nondiabetic hemodialysis patients: effects of high energy supplementation. Am J Clin Nutr. 2009;90:64–9.
Hen JL. Insulin resistance and risk of chronic kidney disease in non diabetic US adults. J Am Soc Nephrol. 2003;14(2):469–77.
AlZadjali MA, Godfrey V, et al. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol. 2009;53(9):747–53.
Rashid S, Patterson BW, Lewis GF. Thematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans. J Lipid Res. 2006;47(1):631–1642.
Xiao C, Watanabe T, et al. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia. Circ Res. 2008;103:159–66.
Ben Ounis O, Elloumi M, et al. Effects of two-month physical-endurance and diet-restriction programmes on lipid profiles and insulin resistance in obese adolescent boys. Diabetes Metab. 2008;34(6 Pt 1):595–600.
Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med. 1992;231(1):25–30.
Borissova AM, Djambazova A, et al. Effect of erythropoietin on the metabolic and peripheral insulin sensitivity in diabetic patients on hemodialysis. Nephrol Dial Transplant. 1993;8:93–5.
Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92:491–6.
Kobayashi S, Maejima S, Ikeda T, Nagase M. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2000;15:65–70.
CrossRef PubMed Copyright information
© Springer Science+Business Media, LLC 2009